Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin

Journal of Biomaterials Science, Polymer Edition

Volumn 26, Issue 11, 2015, Pages 629-643

  Cong, Yingying ^a,b   Quan, Changyun ^b   Liu, Meiqing ^a   Liu, Jie ^b   Huang, Gang ^b   Tong, Guoquan ^b   Yin, Yihua ^a   Zhang, Chao ^b   Jiang, Qing ^b  

^a WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

alendronate; bone targeting; nanoparticles; osteomyelitis; vancomycin

Indexed keywords

BACTERIA; BIODEGRADABLE POLYMERS; BIOMATERIALS; BONE; COPOLYMERS; CRITICAL MICELLE CONCENTRATION; DRUG PRODUCTS; LACTIC ACID; LIGHT SCATTERING; LIGHT TRANSMISSION; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

ALENDRONATE; BONE TARGETING; MICELLE CONCENTRATIONS; OSTEOMYELITIS; POLY(LACTIC ACID-CO-GLYCOLIC ACID); PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRONIC MICROSCOPIES; VANCOMYCIN;

MICELLES;

ALENDRONIC ACID; MACROGOL; POLYGLACTIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG CARRIER; HYDROXYAPATITE; LACTIC ACID; MACROGOL DERIVATIVE; MICELLE; NANOPARTICLE; POLYLACTIC ACID; POLYMER;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BIODEGRADABILITY; BONE MARROW STROMA CELL; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; LIVER CELL; MICELLE; MTT ASSAY; NONHUMAN; OSTEOMYELITIS; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BONE; CELL LINE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; DRUG RELEASE; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; RAT; TUMOR CELL LINE;

RATTUS; STAPHYLOCOCCUS AUREUS;

ALENDRONATE; ANIMALS; ANTI-BACTERIAL AGENTS; BONE AND BONES; CELL LINE; CELL LINE, TUMOR; DRUG CARRIERS; DRUG LIBERATION; DURAPATITE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICELLES; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; RATS; VANCOMYCIN;

EID: 84934435402     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2015.1053170     Document Type: Article

References (33)

1. Ferreira SM, Domingos GP, Rocha TG, et al. Technetium-99 m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitis. Bioorg. Med. Chem. Lett. 2012; 22: 4605-4608.
2. Jiang JL, Li YF, Fang TL, et al. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflammation Res. 2012; 61: 207-215. 10.1007/s00011-011-0402-x
3. Shi SF, Zhang XL, Zhu C, et al. Ultrasonically enhanced rifampin activity against internalized Staphylococcus aureus. Exp. Ther. Med. 2013; 5: 257-262.
4. Xiong MH, Bao Y, Yang XZ, et al. Delivery of antibiotics with polymeric particles. Adv. Drug Delivery Rev. 2014; 78: 63-76. 10.1016/j.addr.2014.02.002
5. Pillai RR, Somayaji SN, Rabinovich M, et al. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed. Mater. 2008; 3: 3750-3756.
6. Peng K, Chen C, Chu I, et al. Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. Biomaterials. 2010; 31: 5227-5236. 10.1016/j.biomaterials.2010.03.027
7. Uskoković V, Desai TA. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis. J. Pharm. Sci. 2014; 103: 567-579. 10.1002/jps.2014.103.issue-2
8. Shea JE, Miller SC. Skeletal function and structure: Implications for tissue-targeted therapeutics. Adv. Drug Delivery Rev. 2005; 57: 945-957. 10.1016/j.addr.2004.12.017
9. Swami A, Reagan MR, Basto P, et al. Engineered nanomedicine for myeloma and bone microenvironment targeting. PNAS USA. 2014; 111: 10287-10292. 10.1073/pnas.1401337111
10. Hengst V, Oussoren C, Kissel T, et al. Bone targeting potential of bisphosphonate-targeted liposomes: Preparation, characterization and hydroxyapatite binding in vitro. Int. J. Pharm. 2007; 331: 224-227. 10.1016/j.ijpharm.2006.11.024
11. Jahnke W, Henry C. An in vitro assay to measure targeted drug delivery to bone mineral. Chem. Med. Chem. 2010; 5: 770-776. 10.1002/cmdc.201000016
12. De Miguel L, Noiray M, Surpateanu G, et al. Poly(γ-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting. Int. J. Pharm. 2014; 460: 73-82. 10.1016/j.ijpharm.2013.10.048
13. Miller K, Clementi C, Polyak D, et al. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Biomaterials. 2013; 34: 3795-3806. 10.1016/j.biomaterials.2013.01.052
14. Thamake SI, Raut SL, Gryczynski Z, et al. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials. 2012; 33: 7164-7173. 10.1016/j.biomaterials.2012.06.026
15. Tosi G, Rivasi F, Gandolfi F, et al. Conjugated poly(D, l-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles. Biomaterials. 2005; 26: 4189-4195. 10.1016/j.biomaterials.2004.10.025
16. Locatelli E, Comes Franchini M. Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system. J. Nanopart. Res. 2012; 14: 1316-1332. 10.1007/s11051-012-1316-4
17. Nogueira E, Loureiro A, Nogueira P, et al. Liposome and protein based stealth nanoparticles. Faraday Discuss. 2013; 166: 417-429. 10.1039/c3fd00057e
18. Aguiar J, Carpena P, Molina-Bolvar JA, et al. On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J. Colloid Interface Sci. 2003; 258: 116-122. 10.1016/S0021-9797(02)00082-6
19. Owensiii DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006; 307: 93-102. 10.1016/j.ijpharm.2005.10.010
20. Wang D, Miller S, Sima M, et al. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems. Bioconjugate Chem. 2003; 14: 853-859. 10.1021/bc034090j
21. Zhong Y, Yang W, Sun H, et al. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Biomacromolecules. 2013; 14: 3723-3730. 10.1021/bm401098w
22. Basu Ray G, Chakraborty I, Moulik SP. Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity. J. Colloid Interface Sci. 2006; 294: 248-254.
23. Xiao Y, Hong H, Javadi A, et al. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials. 2012; 33: 3071-3082. 10.1016/j.biomaterials.2011.12.030
24. Fuchs S, Pane-Farre J, Kohler C, et al. Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 2007; 189: 4275-4289. 10.1128/JB.00081-07
25. Miller K, Erez R, Segal E, et al. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. Angew. Chem. Int. Ed. 2009; 48: 2949-2954. 10.1002/anie.200805133
26. Chen H, Li G, Chi H, et al. Alendronate-conjugated amphiphilic hyperbranched polymer based on boltorn H40 and poly(ethylene glycol) for bone-targeted drug delivery. Bioconjugate Chem. 2012; 23: 1915-1924. 10.1021/bc3003088
27. Pignatello R, Cenni E, Micieli D, et al. A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. Nanomedicine. 2009; 4: 161-175. 10.2217/17435889.4.2.161
28. Yewle JN, Puleo DA, Bachas LG. Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone. Bioconjugate Chem. 2011; 22: 2496-2506. 10.1021/bc2003132
29. De Miguel L, Noiray M, Surpateanu G, et al. Poly(γ-benzyl-l-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting. Int. J. Pharm. 2014; 460: 73-82. 10.1016/j.ijpharm.2013.10.048
30. Liu X-M, Wiswall AT, Rutledge JE, et al. Osteotropic β-cyclodextrin for local bone regeneration. Biomaterials. 2008; 29: 1686-1692. 10.1016/j.biomaterials.2007.12.023
31. Rawls HR, Cabasso I. Adsorption of phosphonylated polyelectrolytes on hydroxyapatite. In: Misra D., editor. Adsorption on and surface chemistry of hydroxyapatite. New York (NY): Springer; 1984. p. 115-128. 10.1007/978-1-4757-9012-2
32. Aleksandar F R-M, Lu Timothy K, Puscasu Vlad A, et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012; 6: 4279-4287.
33. Mercier RC. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium. J. Antimicrob. Chemother. 2002; 50: 19-24. 10.1093/jac/dkf058